Advanced Medical Solutions GroupCHIX:AMSL -0.09%93 5-Year Yield-on-Cost % is 1.70 as of Jul. 08, 2026, which is 67% above its 10-year median of 1.02. GuruFocus rates CHIX:AMSL with a GF Score™ of 93/100 and a GF Value™ of £3.72 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 327 Medical Devices & Instruments companies, Advanced Medical Solutions Group ranks worse than 58.41% on this metric.
The historical rank and industry rank for Advanced Medical Solutions Group's 5-Year Yield-on-Cost % or its related term are showing as below:
CHIX:AMSl'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.43 Med: 1.02 Max: 2.35
Current: 1.7
During the past 13 years, Advanced Medical Solutions Group's highest Yield on Cost was 2.35. The lowest was 0.43. And the median was 1.02.
CHIX:AMSl's 5-Year Yield-on-Cost % is ranked worse than 58.41% of 327
companies
in the Medical Devices & Instruments industry
Industry Median: 2.31
vs CHIX:AMSl: 1.70
Advanced Medical Solutions Group (CHIX:AMSl) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Advanced Medical Solutions Group 5-Year Yield-on-Cost % Related Terms
CHIX:AMSL vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Medical Solutions Group 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Advanced Medical Solutions Group's 5-Year Yield-on-Cost % falls into.
Advanced Medical Solutions Group 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Advanced Medical Solutions Group (CHIX:AMSL) has a 5-Year Yield-on-Cost % of 1.70 as of Jul. 08, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Advanced Medical Solutions Group and its competitors. This is 67% above median its historical median of 1.02. Over the past decade, Advanced Medical Solutions Group's 5-Year Yield-on-Cost % has ranged from 0.43 to 2.35. According to the industry distribution chart, Advanced Medical Solutions Group ranks #191 out of 327 companies in the Medical Devices & Instruments industry, placing it in the top 58.4%.
Is Advanced Medical Solutions Group's 5-Year Yield-on-Cost % too high?
Advanced Medical Solutions Group's current 5-Year Yield-on-Cost % of 1.70 is 67% above median its 10-year median of 1.02. Over the past 10 years, this metric has ranged from a low of 0.43 to a high of 2.35. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.31. Advanced Medical Solutions Group's value of 1.70 is 26.4% below this industry median. Based on the distribution chart, Advanced Medical Solutions Group ranks #191 out of 327 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Advanced Medical Solutions Group has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Solutions Group ranks #191 out of 327 companies for 5-Year Yield-on-Cost %. This places Advanced Medical Solutions Group in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.31. Advanced Medical Solutions Group's value of 1.70 is 26.4% below this benchmark. Historically, Advanced Medical Solutions Group's own 5-Year Yield-on-Cost % has ranged from 0.43 to 2.35 over the past decade. While the company's 10-year median is 1.02 vs. the industry median of 2.31, Advanced Medical Solutions Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.31, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Medical Solutions Group's current 5-Year Yield-on-Cost % of 1.70 is 26.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Advanced Medical Solutions Group and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Medical Solutions Group's current 5-Year Yield-on-Cost % is 1.70, which is 67% above median its own 10-year median of 1.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.72, compared to a current price of £2.80 — trading 24.8% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.70, which is 67% above median its 10-year median of 1.02 and 26.4% below the Medical Devices & Instruments industry median of 2.31. Advanced Medical Solutions Group's overall GF Score™ is 93/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current 5-Year Yield-on-Cost % is 1.70 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued.
The current stock price of £2.80 is trading 24.8% below its estimated GF Value™ of £3.72.
GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.
Key valuation signals for CHIX:AMSL:
5-Year Yield-on-Cost %: 1.70 (67% above median its 10-year median of 1.02)
GF Value™: £3.72 vs. price of £2.80 (24.8% below fair value)
Industry Position: 26.4% below the Medical Devices & Instruments median (#191 of 327)
No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Medical Solutions Group Business Description
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
93GF Score
Get the complete analysis for CHIX:AMSL
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMSL has been successfully added to your 